- Home
- SVRA vs JELD Comparison
SVRA vs JELD Comparison
Compare SVRA & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- JELD
- Stock Information
- Founded
- SVRA 2007
- JELD 1960
- Country
- SVRA United States
- JELD United States
- Employees
- SVRA N/A
- JELD N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- JELD Forest Products
- Sector
- SVRA Health Care
- JELD Basic Materials
- Exchange
- SVRA Nasdaq
- JELD Nasdaq
- Market Cap
- SVRA 527.2M
- JELD 545.7M
- IPO Year
- SVRA N/A
- JELD 2017
- Fundamental
- Price
- SVRA $3.53
- JELD $5.54
- Analyst Decision
- SVRA Buy
- JELD Hold
- Analyst Count
- SVRA 8
- JELD 8
- Target Price
- SVRA $6.63
- JELD $6.03
- AVG Volume (30 Days)
- SVRA 1.7M
- JELD 2.0M
- Earning Date
- SVRA 11-11-2025
- JELD 11-03-2025
- Dividend Yield
- SVRA N/A
- JELD N/A
- EPS Growth
- SVRA N/A
- JELD N/A
- EPS
- SVRA N/A
- JELD N/A
- Revenue
- SVRA N/A
- JELD $3,430,185,000.00
- Revenue This Year
- SVRA N/A
- JELD N/A
- Revenue Next Year
- SVRA N/A
- JELD $2.38
- P/E Ratio
- SVRA N/A
- JELD N/A
- Revenue Growth
- SVRA N/A
- JELD N/A
- 52 Week Low
- SVRA $1.89
- JELD $3.27
- 52 Week High
- SVRA $4.70
- JELD $16.43
- Technical
- Relative Strength Index (RSI)
- SVRA 59.38
- JELD 42.56
- Support Level
- SVRA $3.47
- JELD $6.10
- Resistance Level
- SVRA $3.72
- JELD $6.51
- Average True Range (ATR)
- SVRA 0.18
- JELD 0.33
- MACD
- SVRA -0.04
- JELD -0.14
- Stochastic Oscillator
- SVRA 42.50
- JELD 2.37
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.